RESEARCH ON hs-CRP AND RELATIONSHIP TO SOME CLINICAL AND SUBCLINICAL FACTORS IN TYPE 2 DIABETES PATIENTS
Main Article Content
Abstract
Background: Prolonged in inflammation causes vascularcomplications in diabetes. If not controlled and treated promptly, the patient can become disabled and die. Blood hs-CRP test as a useful biomarker of chronic vasculitis, in order to support diagnosis, monitor treatment and detect complications effectively for patients with type 2 diabetes.
Aim: To examine the correlation between blood hs-CRP levels and some biochemical test index (glucose, HbA1c, total cholesterol, LDL-C, HDL-C and triglyceride) in type 2 diabetes patient.
Sample: 238 pepple divided into two groups: group of 118 patients with type 2 diabetes and group of 220 healthy people (control group) having age and gender equivalent to the patient group.
Method: A cross-sectional descriptive study. Patients under clinical examination, history abstraction, intravenous blood werw measured levels of hs-CRP, glucose,HbA1c, total cholesterol, LDL-C, HDL-C and triglyceride. Diagnose type 2 diabetes according to ADA 2020.
Results: Blood hs-CRP (mg/L) in the patient and control groups were 3,9 ± 1,7 compared to 1,7 ± 1,1mg/L (p<0,001). This difference is statistically significant. Patients with high levels of hs-CRP at high and average rick for heart disease were 99.2%. In which, the percentage of patients at high, medium and low levels were72.9; 26.3 and 0.8 respectively. Blood hs-CRP levels were positive correlated with glucose, HbA1c,total cholesterol, LDL-C and triglyceride, inverse correlated with triglyceride Conclusion: The blood hs-CRP levels in type 2 diabetes patients were higher than control group. There is a positive correlation between hs-CRP levels in blood with glucose, HbA1c, total cholesterol, LDL-C and triglyceride, nagative correlated with triglyceride.
Keywords
hs-CRP, type 2 diabetes
Article Details
References
Vinh Phạm Nguyễn, Đái Tháo Đường và bệnh Mạch Vành (2012), tầm quan trọng của kiểm soát tích cực LDL-C, Hội nghị khoa học toàn quốc lần VI của hội Nội tiết và Đái tháo đường Việt Nam, 2012, tr. 152.
Aljack HA, High Sensitive C (2019). Reactive Protein in Sudanese Type 2 Diabetic Patients, Sudan Journal of Medical Sciences, 2019, pp. 132-142.
Elimam H et al. (2018), Inflammatory markers and control of type 2 diabetes mellitus, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018, pp. 800-804.
Kashinakunti SV, Serum High Sensitive - C (2016). Reactive Protein Levels in Type 2 Diabetes Mellitus -A Case Control Study, International Journal of Biochemistry Research & Review, 2016, pp. 1-8.
Roopakala MS (2012), Evaluation of high sensitivity creactive protein and glycated hemoglobin levels in diabetic nephropathy, Saudi Journal of kidney diseases and transplantation, 2012, pp. 286.
Singh M (2020), High-sensitivity C-reactive protein, Malondialdehyde and their association with Glycated hemoglobin (HbA1c) in type 2 diabetes patients, International Journal of Health and Clinical Research, 2020, pp. 81-86.
Singh N (2019), A cross-sectional study on association of high-sensitivity C-reactive proteins (HS-CRP) with dyslipidemia in type 2 diabetic patients of Haryana region, International J. of Healthcare and Biomedical Research, 2019, pp. 30-39.